| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000020189 |
| Receipt No. | R000023318 |
| Official scientific title of the study | Anti-obesity effect of the plant extract in subjects with abdominal obesity |
| Date of disclosure of the study information | 2015/12/15 |
| Last modified on | 2017/06/15 (Ver. 4) |
| Basic information | ||
| Official scientific title of the study | Anti-obesity effect of the plant extract in subjects with abdominal obesity | |
| Title of the study (Brief title) | Anti-obesity effect of the plant extract in subjects with abdominal obesity | |
| Region |
|
|
| Condition | ||
| Condition | Healthy volunteers | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To investigate the effect of the plant extract on adiposity-related parameters in subjects with abdominal obesity. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Visceral fat area at baseline, 8, 12 and 16 weeks. |
| Key secondary outcomes | Body weight, body fat percentage, and waist circumference at baseline, 8, 12 and 16 weeks. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | NO |
| Dynamic allocation | NO |
| Institution consideration | |
| Blocking | YES |
| Concealment | Central registration |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Subjects receive 350 mL/day of placebo drink for 12 weeks, by replacing their daily alcoholic drinks with it. | |
| Interventions/Control_2 | Subjects receive 350 mL/day of treatment drink (containing 540 mg of the plant extract) for 12 weeks, by replacing their daily alcoholic drinks with it. | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) Regular user of alcohol (more than 5 days per week)
2) Visceral fat area not lower than 100 cm2 |
|||
| Key exclusion criteria | 1) Taking medicines or receiving health guidance for hypertension, diabetes, and/or hyperlipidemia
2) Taking drugs or functional food that may affect the trial 3) Participation in any clinical trial within 90 days of the commencement of the trial 4) In pregnancy or nursing a child 5) Cardiac, renal, and/or hepatic dysfunction 6) History of severe disease and/or major surgery |
|||
| Target sample size | 60 | |||
| Research contact person | |
| Name of lead principal investigator | Fumiko Higashikawa |
| Organization | Hiroshima University, Institute of Biomedical & Health Sciences |
| Division name | Project Research Center for Clinical Trial and Preventive Medicine |
| Address | Kasumi 1-2-3, Minami-ku, Hiroshima 734-8551, JAPAN |
| TEL | 082-257-1533 |
| fumiko@hiroshima-u.ac.jp | |
| Public contact | |
| Name of contact person | Fumiko Higashikawa |
| Organization | Hiroshima University, Institute of Biomedical & Health Sciences |
| Division name | Project Research Center for Clinical Trial and Preventive Medicine |
| Address | Kasumi 1-2-3, Minami-ku, Hiroshima 734-8551, JAPAN |
| TEL | 082-257-1533 |
| Homepage URL | |
| fumiko@hiroshima-u.ac.jp | |
| Sponsor | |
| Institute | Hiroshima University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Kao Corporation |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 広島大学病院(広島県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000023318 |